Package 59572-820-30

Brand: zeposia

Generic: ozanimod hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59572-820-30
Digits Only 5957282030
Product NDC 59572-820
Description

30 CAPSULE in 1 BOTTLE, PLASTIC (59572-820-30)

Marketing

Marketing Status
Marketed Since 2020-03-27
Brand zeposia
Generic ozanimod hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47f2242f-a571-48a8-985a-8fa4f79ec12f", "openfda": {"unii": ["3UPR33JAAM"], "rxcui": ["2288406", "2288412", "2288414", "2288416", "2288418", "2288420", "2288430", "2288431", "2288432", "2288433", "2642213", "2642214"], "spl_set_id": ["93ce2fab-edfb-4804-8074-963071de51e4"], "manufacturer_name": ["Celgene Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (59572-820-30)", "package_ndc": "59572-820-30", "marketing_start_date": "20200327"}], "brand_name": "ZEPOSIA", "product_id": "59572-820_47f2242f-a571-48a8-985a-8fa4f79ec12f", "dosage_form": "CAPSULE", "pharm_class": ["Sphingosine 1-Phosphate Receptor Modulators [MoA]", "Sphingosine 1-phosphate Receptor Modulator [EPC]"], "product_ndc": "59572-820", "generic_name": "ozanimod hydrochloride", "labeler_name": "Celgene Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZEPOSIA", "active_ingredients": [{"name": "OZANIMOD HYDROCHLORIDE", "strength": ".92 mg/1"}], "application_number": "NDA209899", "marketing_category": "NDA", "marketing_start_date": "20200327", "listing_expiration_date": "20261231"}